Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Philippe Collet

Showing results (71-80 of 376) with videos related to

Pageof 38
Sort By:
European Heart Journal|August 24, 2018
Management of antithrombotic therapy in AF patients presenting with ACS and/or undergoing PCI: A Summary of the Joint Consensus Document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA)Gregory Y H Lip, Jean-Philippe Collet, Michael Haude, et al.
Presse Medicale (Paris, France : 1983)|April 23, 2011
[Myocardial infarction: Role of new antiplatelet agents]Johanne Silvain, Anne Bellemain, Patrick Ecollan, et al.
JAMA|July 22, 2004
Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysisGilles Montalescot, Maria Borentain, Laurent Payot, et al.
European Heart Journal|August 31, 2015
Questions and answers on coronary revascularization: a companion document of the 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationMarco Valgimigli, Carlo Patrono, Jean-Philippe Collet, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Mechanisms and Definitions of Periprocedural Myocardial Infarction in the Era of Modern RevascularizationArnaud Ferrante, Paul Guedeney, Johanne Silvain, et al.
European Heart Journal|August 31, 2015
Questions and answers on diagnosis and risk assessment: a companion document of the 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationChristian Mueller, Carlo Patrono, Marco Valgimigli, et al.
Journal of the American College of Cardiology|October 3, 2006
Percutaneous coronary intervention after fibrinolysis: a multiple meta-analyses approach according to the type of strategyJean-Philippe Collet, Gilles Montalescot, Michel Le May, et al.
International Journal of Cardiology|June 20, 2012
An evidence-based review of current anti-platelet options for STEMI patientsGuillaume Cayla, Johanne Silvain, Stephen A O'Connor, et al.
Circulation|January 19, 2006
Images in cardiovascular medicine. Architecture of intracoronary thrombi in ST-elevation acute myocardial infarction: time makes the differenceFarzin Beygui, Jean-Philippe Collet, Chandrasekaran Nagaswami, et al.
JACC. Cardiovascular Interventions|December 21, 2022
Reply: Oral Anticoagulant Dose Adjustment After TAVR: The Role of Closure Time With Adenosine DiphosphateJean-Philippe Collet, Eric Van Belle, Paul Guedeney, et al.
Pageof 38

Showing results (71-80 of 376) with videos related to

Sort By:
Pageof 38
European Heart Journal|August 24, 2018
Management of antithrombotic therapy in AF patients presenting with ACS and/or undergoing PCI: A Summary of the Joint Consensus Document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA)Gregory Y H Lip, Jean-Philippe Collet, Michael Haude, et al.
Presse Medicale (Paris, France : 1983)|April 23, 2011
[Myocardial infarction: Role of new antiplatelet agents]Johanne Silvain, Anne Bellemain, Patrick Ecollan, et al.
JAMA|July 22, 2004
Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysisGilles Montalescot, Maria Borentain, Laurent Payot, et al.
European Heart Journal|August 31, 2015
Questions and answers on coronary revascularization: a companion document of the 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationMarco Valgimigli, Carlo Patrono, Jean-Philippe Collet, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Mechanisms and Definitions of Periprocedural Myocardial Infarction in the Era of Modern RevascularizationArnaud Ferrante, Paul Guedeney, Johanne Silvain, et al.
European Heart Journal|August 31, 2015
Questions and answers on diagnosis and risk assessment: a companion document of the 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationChristian Mueller, Carlo Patrono, Marco Valgimigli, et al.
Journal of the American College of Cardiology|October 3, 2006
Percutaneous coronary intervention after fibrinolysis: a multiple meta-analyses approach according to the type of strategyJean-Philippe Collet, Gilles Montalescot, Michel Le May, et al.
International Journal of Cardiology|June 20, 2012
An evidence-based review of current anti-platelet options for STEMI patientsGuillaume Cayla, Johanne Silvain, Stephen A O'Connor, et al.
Circulation|January 19, 2006
Images in cardiovascular medicine. Architecture of intracoronary thrombi in ST-elevation acute myocardial infarction: time makes the differenceFarzin Beygui, Jean-Philippe Collet, Chandrasekaran Nagaswami, et al.
JACC. Cardiovascular Interventions|December 21, 2022
Reply: Oral Anticoagulant Dose Adjustment After TAVR: The Role of Closure Time With Adenosine DiphosphateJean-Philippe Collet, Eric Van Belle, Paul Guedeney, et al.
Pageof 38